$WST (West Pharmaceutical Services, Inc.)

$WST {{ '2016-09-12T12:20:38+0000' | timeago}} • Announcement

Pharmaceutical packaging systems maker $WST said its BoD has elected Paolo Pucci, CEO of $ARQL, as an independent director following the retirement of Anthony Welters.

$AMGN {{ '2018-01-19T13:28:13+0000' | timeago}} • Announcement

The European Commission (EC) has granted marketing authorization for MVASI from $AMGN and $AGN. MVASI is the first biosimilar bevacizumab approved by the EC and is approved for the treatment of certain types of cancers.

$WRK {{ '2018-01-17T18:04:33+0000' | timeago}} • Announcement

$WRK has named James Armstrong as Vice President, Investor Relations. Most recently, Armstrong covered the paper, packaging and building materials industry through his own investment research firm. Prior to this, he was Vice President and Chief Technology Officer of Vertical Research Partners.

$AGN {{ '2018-01-17T13:14:16+0000' | timeago}} • Announcement

$AGN and $IRWD reached an agreement with Indian pharma company Sun Pharma to resolve a patent litigation for the generic version of constipation drug Linzess in the U.S. As per the agreement, Sun Pharma will be able to market the generic version of Linzess in the U.S. from Feb. 1, 2031. All the litigations related to Linzess were dismissed.

$HOLX {{ '2018-01-16T13:05:50+0000' | timeago}} • Announcement

$HOLX said its CE-marked Aptima HIV-1 Quant Dx assay has been awarded World Health Organization (WHO) prequalification for in vitro diagnostic. The Aptima HIV-1 Quant Dx assay is the first HIV-1 viral load assay with a dual claim for both diagnosis and treatment monitoring.

$HOLX {{ '2018-01-11T21:23:15+0000' | timeago}} • Announcement

Medical technology company $HOLX has elected Namal Nawana to its board of directors, effective immediately. Nawana was formerly the CEO of Alere, Inc. Prior to that, he served Johnson & Johnson in various leadership roles, including Worldwide President of DePuy Synthes Spine.

$AGN {{ '2018-01-09T15:46:35+0000' | timeago}} • Announcement

$AGN, which announced its plan to give pink slips to 1,000 of its employees and cut down 400 open positions earlier this year, provided FY18 financial outlook. In 2018, Allergan plans to sell its remaining position of 10% stake in $TEVA through Forward Sale Agreements and/or open market sales.

$HOLX {{ '2018-01-08T13:10:32+0000' | timeago}} • Announcement

Medical technology company $HOLX said it is currently looking for net revenues of about $791MM for the first quarter of 2018, higher than $775MM-$790MM the company had estimated earlier. The latest guidance represents an 8% YoY growth, reflecting the effect of divestiture of Hologic’s blood screening business and acquisition of Cynosure.

$WRK {{ '2018-01-08T12:11:46+0000' | timeago}} • Announcement

$WRK completed the previously announced acquisition of Plymouth Packaging, Inc., a corrugated packaging company. This latest acquisition represents $WRK's entry into the corrugated packaging market. Financial details of the deal remained undisclosed.

$HOLX {{ '2018-01-03T13:10:03+0000' | timeago}} • Announcement

$HOLX said the MyoSure MANUAL device, which was designed to simplify tissue removal procedures regardless of setting, has received CE mark in Europe. The MyoSure MANUAL device joins the MyoSure suite of gynecologic surgical products that offer simple and effective solutions to resect and remove tissue.

$AGN {{ '2017-12-26T12:22:55+0000' | timeago}} • Announcement

$AGN said that the Federal Circuit confirmed that a proposed generic version of Combigan eye drug from Sandoz, a unit of $NVS, did not infringe Allergan's two patents. The Federal Circuit also reversed the district court's decision that Sandoz's proposed generic product infringes Allergan's 3rd patent. Allergan plans to file for rehearing within 30 days.

$WST {{ '2017-12-22T12:59:41+0000' | timeago}} • Announcement

$WST BoD approved 1Q18 dividend of $0.14 per share. The dividend will be paid on February 1, 2018, to shareholders of record as of January 18, 2018.

$AGN {{ '2017-12-21T14:38:43+0000' | timeago}} • Announcement

$AGN and its partner $PRTK announced that FDA accepted to review Seysara, an investigational drug for treating acne. Allergan, which has the U.S. rights of developing and marketing Seysara, expects FDA to take action on this in 2H18. Paratek retains the non-U.S. rights. In March 2017, Allergan announced positive results from Seysara Phase 3 trials.

$SLGN {{ '2017-12-19T12:24:29+0000' | timeago}} • Announcement

$SLGN BoD declared a $0.18 per share quarterly cash dividend on its common stock. The dividend is payable on March 30, 2017 to the holders of record of the common stock of the Company on March 16, 2017.

$AGN {{ '2017-12-18T22:26:29+0000' | timeago}} • Announcement

Robert Stewart, COO of $AGN will resign from his role. He has been named as the CEO of the newly formed Amneal Pharmaceuticals, effective Jan. 25, 2018. Following Rob's departure, Wayne Swanton, SVP, Global Operations has been promoted as EVP, Global Operations of Allergan.

$AGN {{ '2017-12-18T22:14:14+0000' | timeago}} • Announcement

$AGN and its development partner Gedeon Richter Plc reported positive results from phase 3 study of cariprazine, which is used to treat the bipolar depression. Allergan plans to file the New Drug Application to the FDA in 2H18.

$IPXL {{ '2017-12-18T13:05:53+0000' | timeago}} • Announcement

Amneal Pharmaceuticals LLC and $IPXL said Robert Stewart will join Amneal as President, effective Jan. 25, 2018. Stewart most recently served as COO of $AGN. After completion of combination of Amneal and $IPXL, Stewart will become President and CEO of the combined company, to be named Amneal Pharmaceuticals Inc., and will become a BoD member.

$ALB {{ '2017-12-15T11:54:52+0000' | timeago}} • Announcement

Global specialty chemicals industry leader $ALB said it has signed a definitive agreement to sell its polyolefin catalysts and components business to $GRA in cash for approx. $416MM. The organometallics and curatives portions of the Performance Catalysts Solutions business will remain with $ALB. The deal is expected to close during 1Q18.

$PKG {{ '2017-12-15T11:49:18+0000' | timeago}} • Announcement

$PKG BoD declared a regular quarterly dividend of $0.63 per share on its common stock. The dividend will be paid to shareholders of record as of Dec. 26, 2017 with a payment date of Jan. 12, 2018.

$CSL {{ '2017-12-13T15:11:34+0000' | timeago}} • Announcement

$CSL announced that Jesse Singh, Chief Executive Officer of CPG International, has been elected to its Board of Directors, effective immediately.

$AGN {{ '2017-12-12T19:58:45+0000' | timeago}} • Announcement

$AGN gets FDA clearance for the CoolSculpting, a treatment to improve the appearance of lax tissue in double chin. Allergan got this CoolSculpting technology by acquiring Zeltiq Aesthetics in Feb. 2017 for $2.4Bil. Allergan added that in an 18-week study, 77% of patients showed improved appearance in their lax tissue.

Recent Transcripts

URG (UR-Energy Inc.)
Friday, January 19 2018 - 4:00pm
RAVN (Raven Industries Inc.)
Tuesday, November 21 2017 - 3:00pm
MDWD (MediWound Ltd.)
Thursday, November 16 2017 - 1:30pm
HOLX (Hologic Inc.)
Wednesday, November 8 2017 - 9:30pm
ASH (Ashland Inc.)
Tuesday, November 7 2017 - 2:00pm
VGZ (Vista Gold Corp.)
Thursday, November 2 2017 - 8:30pm
MLM (Martin Marietta Materials, Inc.)
Thursday, November 2 2017 - 3:00pm
SAND (Sandstorm Gold Ltd.)
Thursday, November 2 2017 - 3:00pm
WRK (WestRock Company)
Thursday, November 2 2017 - 12:30pm
CLX (The Clorox Company)
Wednesday, November 1 2017 - 5:30pm
STE (Steris Plc)
Wednesday, November 1 2017 - 2:00pm
AGN (Allergan plc)
Wednesday, November 1 2017 - 12:30pm
IPHS (Innophos Holdings Inc)
Tuesday, October 31 2017 - 1:00pm
TGB (Taseko Mines Ltd.)
Friday, October 27 2017 - 3:00pm
WST (West Pharmaceutical Services, Inc.)
Thursday, October 26 2017 - 1:00pm
PKG (Packaging Corporation of America)
Thursday, October 26 2017 - 1:00pm
SLGN (Silgan Holdings Inc.)
Wednesday, October 25 2017 - 3:00pm
USNA (USANA Health Sciences Inc.)
Wednesday, October 25 2017 - 3:00pm
IP (International Paper Company)
Wednesday, October 25 2017 - 2:00pm
GRA (W.R. Grace & Co.)
Wednesday, October 25 2017 - 1:00pm

AlphaGraphics you may like